We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

86 hedge funds and large institutions have $177M invested in ChemoCentryx, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 24

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 88 → 86 (-2)

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

23% less capital invested

Capital invested by funds: $228M → $177M (-$51.5M)

Holders
86
Holders Change
-2
Holders Change %
-2.27%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
31
Reduced
24
Closed
14
Calls
$201K
Puts
–
Net Calls
+$201K
Net Calls Change
+$304K

Top Buyers

1
BlackRock
BlackRock
New York
+$3.69M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.69M
3
Goldman Sachs
Goldman Sachs
New York
+$1.22M
4
Millennium Management
Millennium Management
New York
+$814K
5
ZIM
Zacks Investment Management
Illinois
+$660K

Top Sellers

1
BI
BVF Inc
California
-$5.49M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.23M
3
SCM
Sio Capital Management
New York
-$1.83M
4
EC
EcoR1 Capital
California
-$1.1M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$56.3M -$5.49M -661,000 -8%
BlackRock
2
BlackRock
New York
$20.6M +$3.69M +444,377 +19%
WA
3
Wasatch Advisors
Utah
$16.5M -$305K -36,673 -2%
Franklin Resources
4
Franklin Resources
California
$15.3M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$9.14M +$166K +19,916 +2%
Renaissance Technologies
6
Renaissance Technologies
New York
$6.88M +$1.69M +203,730 +28%
NCM
7
Nantahala Capital Management
Connecticut
$5.03M +$602K +72,426 +12%
AG
8
Artal Group
Luxembourg
$3.71M – – –
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$3.69M -$3.23M -388,247 -44%
State Street
10
State Street
Massachusetts
$3.18M -$9.01K -1,084 -0.3%
Deutsche Bank
11
Deutsche Bank
Germany
$2.34M +$379K +45,591 +17%
Northern Trust
12
Northern Trust
Illinois
$2.05M -$7.71K -928 -0.3%
IHM
13
Iguana Healthcare Management
New York
$2.04M +$208K +25,000 +10%
PAM
14
Panagora Asset Management
Massachusetts
$1.98M +$512K +61,610 +30%
OAM
15
Oxford Asset Management
United Kingdom
$1.85M +$556K +66,910 +37%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$1.82M +$33.8K +4,071 +2%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.79M +$344K +41,437 +21%
Goldman Sachs
18
Goldman Sachs
New York
$1.64M +$1.22M +147,056 +200%
Millennium Management
19
Millennium Management
New York
$1.62M +$814K +97,883 +81%
SIM
20
Spark Investment Management
New York
$1.24M +$336K +40,400 +32%
PAWC
21
P.A.W. Capital
Connecticut
$1.19M – – –
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$888K -$52.4K -6,299 -5%
Invesco
23
Invesco
Georgia
$859K +$42.1K +5,070 +5%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$821K +$32.8K +3,947 +4%
TCIM
25
TIAA CREF Investment Management
New York
$816K – – –
1
2 3 4

CCXI Hedge Fund Activity: Q3 2017 in Review

86 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2017, worth a combined $177M — down 23% from $228M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CCXI and 12 opened new positions — a net loss of 2 holders — while 24 trimmed existing stakes and 31 added.

The largest buyer was BlackRock, adding an estimated $3.69M. The largest seller was BVF Inc, cutting an estimated $5.49M.

  • 86 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2017, down from 88 in Q2 2017.
  • Funds reported $177M of ChemoCentryx, Inc. stock for Q3 2017, down 23% quarter-over-quarter.
  • 12 funds opened new ChemoCentryx, Inc. positions in Q3 2017 and 14 closed out, a net change of -2 holders.
  • The largest ChemoCentryx, Inc. buyer in Q3 2017 was BlackRock, an estimated $3.69M added.
  • The largest ChemoCentryx, Inc. seller in Q3 2017 was BVF Inc, an estimated $5.49M sold.

Based on aggregated 13F filings for Q3 2017.